Understanding how cells stop making proteins and degrade faulty messages
Dynamic interplay of eukaryotic translation and mRNA decay
This study is looking at how cells make proteins and how they stop making them when things go wrong, which could help find new treatments for conditions like Cystic Fibrosis and Duchenne Muscular Dystrophy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10899622 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which cells regulate the translation of messenger RNA (mRNA) into proteins, particularly focusing on how ribosomes identify stop signals to halt protein synthesis. It aims to understand how ribosomes can become trapped on faulty mRNAs and how cellular decay machinery can remove these ribosomes. By using advanced techniques like real-time tracking of ribosomes, the research seeks to uncover fundamental processes that could lead to new treatments for diseases such as Cystic Fibrosis and Duchenne Muscular Dystrophy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic disorders such as Cystic Fibrosis or Duchenne Muscular Dystrophy.
Not a fit: Patients with conditions unrelated to mRNA translation or decay mechanisms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of novel therapies for genetic diseases caused by translation errors.
How similar studies have performed: Other research has shown promising results in understanding mRNA translation and decay, indicating that this approach has potential for success.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Lawson, Michael R — University of California Los Angeles
- Study coordinator: Lawson, Michael R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.